JEAN BUJDOS: Open Payments
NPI 1821595174 · LEHIGHTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 22 payments from 9 companies in 2025. Trend: 2023 $171 · 2024 $399 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $139 |
| Teva Pharmaceuticals USA, Inc. | 6 | $118 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| ABBVIE INC. | 1 | $14 |
Products named: COBENFY, UZEDY, INGREZZA, SPRAVATO, ABILIFY ASIMTUFII, ARISTADA, ZURZUVAE, REXULTI.
Industry payments across PA — which companies pay providers there.
